Please assess the completion status of the following clinical trial:

Trial Title: Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Muslim men and women with Type 2 diabetes.~2. Age 18-78 years~3. Intending to fast during the month of Ramadan~4. On oral antihyperglycemic agents (sulphonylurea based/combination therapy)~Exclusion Criteria:~1. Patient with hypersensitivity or contraindication to Sitagliptin treatment~2. Patient with CKD (creatinine clearance \<50 ml/min)~3. Patients who have participated in another intervention study in the last 2 months~4. Patients who do not give informed consent~5. Pregnant or breast feeding women.~6. Patients on insulin~7. Patients with severe liver disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 78 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Sitagliptin 100mg
- 2 (Type: ACTIVE_COMPARATOR): Sulphonylurea

Based on this trial design, predict the completion outcome and termination type (if applicable).